Loading...

Mizuho Medy Co.,Ltd.

4595.TJPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥1431.00
¥8.00(0.56%)

Mizuho Medy Co.,Ltd. (4595.T) Company Profile & Overview

Explore Mizuho Medy Co.,Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Mizuho Medy Co.,Ltd. (4595.T) Company Profile & Overview

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOFuminari Karakawa

Contact Information

81 9 4285 0303
5-4 Fujinoki-machi, Tosu, 841-0048

Company Facts

187 Employees
IPO DateDec 18, 2015
CountryJP
Actively Trading

Frequently Asked Questions

;